An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of health care solutions, will hold an Investor Meeting on February 27, 2023, at 9:00 a.m. Eastern time. This event will showcase the company's BOLD +1 Strategic Plan aimed at achieving sustainable growth. Key executives, including Stanley M. Bergman and Ronald N. South, will present financial guidance for 2023 and a long-term outlook. Registration is available on the Investor Relations website.
Positive
None.
Negative
None.
MELVILLE, N.Y.--(BUSINESS WIRE)--
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will hold an Investor Meeting on February 27, 2023, at 9:00 a.m. Eastern time. The meeting will provide an opportunity for investors and analysts to hear from members of Henry Schein’s executive leadership team about the Company’s BOLD +1 Strategic Plan for sustainable growth and value creation. The presentation will include details about Henry Schein’s 2023 financial guidance and long-term financial outlook.
Presentations will be made by Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, as well as Ronald N. South, Henry Schein’s Senior Vice President and Chief Financial Officer, and other members of the Company’s Executive Management Committee and senior leadership team.
Registration is available by visiting our Investor Relations website. A replay will be available on the Henry Schein website following the presentation.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021 and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.
